Should S-1 be better than capecitabine for patients with advanced gastric cancer in Asia? A systematic review and meta-analysis.

Should S-1 be better than capecitabine for patients with advanced gastric cancer in Asia? A systematic review and meta-analysis. — المؤلف: Ye, Ziqi — OncoTargets and therapy 2019

المؤلف
Ye, Ziqi
النشر
OncoTargets and therapy 2019
الوصف
269-277 p.